bicalutamide has been researched along with cysteamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Altelaar, M; Ammerlaan, CM; Berkers, CR; Berlingerio, SP; Clevers, H; Essa, K; Jamalpoor, A; Janssen, MJ; Klumperman, J; Levtchenko, E; Lilien, MR; Masereeuw, R; Pou Casellas, C; Rega, LR; Rookmaaker, MB; van der Welle, RE; van Gelder, CA; Verhaar, MC; Veys, KR; Voskuil, K; Yousef Yengej, FA; Zaal, EA | 1 |
1 review(s) available for bicalutamide and cysteamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for bicalutamide and cysteamine
| Article | Year |
|---|---|
Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis.
Topics: Amino Acid Transport Systems, Neutral; Anilides; Animals; Cysteamine; Cystinosis; Humans; Nitriles; Phenotype; Tosyl Compounds; Zebrafish | 2021 |